SARAH BREEN: Open Payments
NPI 1700386703 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 27 payments from 19 companies in 2025. Trend: 2023 $40 · 2024 $121 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $61 |
| Medtronic, Inc. | 1 | $53 |
| Amgen Inc. | 3 | $44 |
| Calliditas Therapeutics US Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Merz Pharmaceuticals, LLC | 1 | $31 |
| Alexion Pharmaceuticals, Inc. | 2 | $31 |
| Novo Nordisk Inc | 2 | $29 |
| Chiesi USA, Inc. | 1 | $29 |
Products named: FREESTYLE LIBRE 3, MINIMED 780G, TARPEYO, MOUNJARO, Kerendia, Xeomin, ULTOMIRIS, TAVNEOS.
Industry payments across ND — which companies pay providers there.
